Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer (Q33370610)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer |
scientific article |
Statements
1 reference
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer (English)
1 reference
David R Gandara
1 reference
Jean-Yves Douillard
1 reference
Luis Paz-Ares
1 reference
Piotr Koralewski
1 reference
Christian Manegold
1 reference
Egbert F Smit
1 reference
José Miguel Reyes
1 reference
Gee-Chen Chang
1 reference
William J John
1 reference
Patrick M Peterson
1 reference
Coleman K Obasaju
1 reference
Michael Lahn
1 reference
1 reference
Identifiers
1 reference